News
2 hours ago
Visara Announces First Patient Dosed in ASCEND Phase 2b Trial of VIS-101 in Wet AMD
Clinical Result
19 Nov 2026
License out/in
19 Nov 2026
Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR)
Clinical ResultDrug Approval
19 Nov 2026
Acquisition
19 Nov 2026
NeuroGenesis Bio Receives FDA Clearance to Proceed with Expanded Access Program for NG01 in Progressive Multiple Sclerosis
Cell TherapyClinical Result
18 Nov 2026
Carnyx Therapeutics Unveils Oral Sleep Candidate CNYX-005 with Preclinical Data Showing Increased NREM Sleep
Clinical Result
Financing
18 Nov 2026
AcquisitionLicense out/in
18 Nov 2026
Acadia Pharmaceuticals Presents Additional Phase 2 RADIANT Study Results Evaluating Remlifanserin for the Treatment of Alzheimer’s Disease Psychosis at the 2026 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Clinical Result
Zealand Pharma announces EU approval of Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome
Clinical ResultDrug ApprovalOrphan Drug